he Biotech Stock Mailbag has a new home. Here’s what readers are saying:

Steve N. writes, “I don’t understand why people are selling Clovis Oncology on this news of a partnership with Bristol-Myers Squibb? Can you explain what I am missing here?”

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.